Skip to main content
. 2026 Jan 12;26:115. doi: 10.1186/s12893-026-03495-x

Table 1.

Timeline of events

Date Event Details
March 20, 2025 Initial outpatient visit Pain and urinary symptoms; adnexal mass detected.
March 26, 2025 Hospital admission on March 26 occurred at the patient’s request due to work-related obligations Labs, inflammatory markers, and tumor markers within normal limits.
March 28–30, 2025 Imaging studies CT: pelvic mass (119 × 83 mm) with heterogeneous enhancement, multiple nodules; MRI: heterogeneous signal, abnormal enhancement; colonoscopy: mucosal erosion, biopsy chronic inflammation (Figs. 1, 2, 3, 4 and 5).
April 1, 2025 Surgical intervention Exploratory laparotomy with palliative resection of retroperitoneal neoplasms, partial colectomy, partial rectal resection, colostomy (Fig. 6a and d).
April 2–13, 2025 Postoperative care Supportive care, gradual diet progression, stoma management; discharged on postoperative day 12.
April 21, 2025 postoperative follow-up of 20 days CT: no evident abnormalities. Patient declined adjuvant therapy due to financial constraints.
July 10, 2025 postoperative follow-up of 100 days Resumption of normal daily activities.
August 24, 2025 postoperative follow-up of 145 days CT: no significant change in residual lesions. Monthly outpatient follow-up continues for stoma care.